In 2021, the production volume of Lactomin amounted to approximately 444.25 thousand kilograms, while around 232.4 thousand Dimethicone tablets were produced in the same period. That year, the production value of Lactomin reached approximately 914.6 million Japanese yen.
Production volume of antidiarrheals and intestinal regulators in Japan in 2021, by agent (in 1,000 units)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Production value of antidiarrheals intestinal regulators Japan 2021, by agent
- Premium Statistic Leading pharmaceutical advertisers online in Russia 2019, by views share
- Premium Statistic Astellas Pharma's total assets FY 2013-2022
- Premium Statistic Astellas Pharma's revenue FY 2022, by region
- Basic Statistic Merck & Co total assets 2009-2022
- Basic Statistic AbbVie's R&D expenditures 2012-2022
- Premium Statistic Daiichi Sankyo's total assets FY 2012-2021
- Premium Statistic Fuji Pharma's sales distribution FY 2022, by therapeutic category
- Premium Statistic Fuji Pharma's total assets FY 2013-2022
- Basic Statistic Fuji Pharma's net sales FY 2013-2022
About the region
10
- Premium Statistic Fuji Pharma's R&D costs FY 2013-2022
- Premium Statistic Takeda Pharmaceutical's net income FY 2012-2021
- Premium Statistic Biosimilar market size Japan 2018-2030
- Premium Statistic Production volume of blood derivatives Japan 2016, by agent
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Basic Statistic Astellas Pharma's revenue FY 2013-2022
- Premium Statistic Astellas Pharma's R&D expenditure FY 2013-2022
- Premium Statistic Astellas Pharma's operating profit FY 2013-2022
- Premium Statistic Astellas Pharma's net profit FY 2013-2022
- Premium Statistic Astellas Pharma's employee numbers FY 2014-2022
Selected statistics
10
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
- Basic Statistic Sanofi's total assets 2007-2022
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Premium Statistic Johnson & Johnson's number of employees 2004-2022
- Basic Statistic GSK's operating profit by division 2006-2021
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
Other regions
10
- Premium Statistic Share of pharma offline ad spend in Russia 2019, by category
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Top internal analgesic brands by ad count in U.S. 2014-2015 and 2015-2016
- Basic Statistic Scotland: primary care consumption of antibiotics 2015-2021, by source
- Basic Statistic Pharmaceutical products against the spread of COVID-19 in Romanian households 2020
- Basic Statistic Antibacterials for systemic use: consumption in Luxembourg 2022
- Basic Statistic Antibacterials for systemic use: consumption in Greece 2022
- Basic Statistic Medicines with the highest expenditure in the Netherlands 2022
- Premium Statistic Pharmaceutical sales value in Mexico 2021, by segment
- Basic Statistic Total R&D expenditure of French pharmaceutical companies 2017
Related statistics
10
- Premium Statistic Daiichi Sankyo's net income FY 2012-2021
- Premium Statistic Daiichi Sankyo's total employees FY 2012-2021
- Premium Statistic Daiichi Sankyo's R&D expenditure FY 2012-2021
- Premium Statistic Alfresa's net sales FY 2013-2022
- Basic Statistic Nipro's net sales FY 2013-2022
- Premium Statistic Takeda Pharmaceutical's number of employees FY 2012-2021
- Premium Statistic Takeda Pharmaceutical's total assets FY 2012-2021
- Premium Statistic Otsuka Holdings' R&D ratio to revenue FY 2013-2022
- Premium Statistic Otsuka Holdings' total employees FY 2013-2022
- Premium Statistic Otsuka Holdings' R&D spending FY 2013-2022
Further related statistics
10
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Pfizer's ad spending 2008-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- CVS Health's total assets 2005-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
Further Content: You might find this interesting as well
Statistics
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Pfizer's ad spending 2008-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- CVS Health's total assets 2005-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
MHLW (Japan). (December 23, 2022). Production volume of antidiarrheals and intestinal regulators in Japan in 2021, by agent (in 1,000 units) [Graph]. In Statista. Retrieved November 28, 2023, from https://www.statista.com/statistics/756826/japan-production-volume-antidiarrheals-intestinal-regulators-by-agent/
MHLW (Japan). "Production volume of antidiarrheals and intestinal regulators in Japan in 2021, by agent (in 1,000 units)." Chart. December 23, 2022. Statista. Accessed November 28, 2023. https://www.statista.com/statistics/756826/japan-production-volume-antidiarrheals-intestinal-regulators-by-agent/
MHLW (Japan). (2022). Production volume of antidiarrheals and intestinal regulators in Japan in 2021, by agent (in 1,000 units). Statista. Statista Inc.. Accessed: November 28, 2023. https://www.statista.com/statistics/756826/japan-production-volume-antidiarrheals-intestinal-regulators-by-agent/
MHLW (Japan). "Production Volume of Antidiarrheals and Intestinal Regulators in Japan in 2021, by Agent (in 1,000 Units)." Statista, Statista Inc., 23 Dec 2022, https://www.statista.com/statistics/756826/japan-production-volume-antidiarrheals-intestinal-regulators-by-agent/
MHLW (Japan), Production volume of antidiarrheals and intestinal regulators in Japan in 2021, by agent (in 1,000 units) Statista, https://www.statista.com/statistics/756826/japan-production-volume-antidiarrheals-intestinal-regulators-by-agent/ (last visited November 28, 2023)
Production volume of antidiarrheals and intestinal regulators in Japan in 2021, by agent (in 1,000 units) [Graph], MHLW (Japan), December 23, 2022. [Online]. Available: https://www.statista.com/statistics/756826/japan-production-volume-antidiarrheals-intestinal-regulators-by-agent/